Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
European Journal of Case Reports in Internal Medicine
|
November 13, 2025
Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease
Nuria Reina-Llompart, Soledad Serrano-López, Gabriel Torres-Iglesias, et al.
European Journal of Case Reports in Internal Medicine
|
November 13, 2025
Erratum: [Erratum] Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease
Nuria Reina-Llompart, Soledad Serrano-López, Gabriel Torres-Iglesias, et al.
Frontiers in Neurology
|
March 8, 2021
A New Software for Quantifying Motor Deficit After Stroke: A Case-Control Feasibility Pilot Study
Raquel Gutiérrez Zúñiga, María Alonso de Leciñana, Alejandro Díez, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Antibody Content against Epstein-Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing-Remitting Multiple Sclerosis
Mireya Fernández-Fournier, MariPaz López-Molina, Gabriel Torres Iglesias, et al.
International Journal of Molecular Sciences
|
October 16, 2024
Differential Protein Expression in Extracellular Vesicles Defines Treatment Responders and Non-Responders in Multiple Sclerosis
Gabriel Torres Iglesias, MariPaz López-Molina, Lucía Botella, et al.
Diseases (Basel, Switzerland)
|
December 24, 2025
Immunological Monitoring During Anti-CD20 Therapies to Predict Infection Risk and Treatment Response in Multiple Sclerosis Patients
Gabriel Torres Iglesias, Ana Martínez-Feito, Laura Otero-Ortega, et al.
Digital Health
|
January 30, 2025
Digital tool as speech and language therapy for patients with post-stroke aphasia
Gerardo Ruiz Ares, Marta Martin Alonso, Ricardo Rigual, et al.
Journal of Neurology
|
April 5, 2024
Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA study
Ricardo Rigual, Jorge Rodríguez-Pardo, Manuel Lorenzo-Diéguez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
June 19, 2025
Extracellular Vesicle-Derived MicroRNAs as a Biomarker for Therapeutic Response in Multiple Sclerosis
Gabriel Torres-Iglesias, MariPaz López-Molina, Rubén Ayala-Suárez, et al.
Frontiers in Immunology
|
November 5, 2025
Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis
MariPaz López-Molina, Gabriel Torres Iglesias, Gonzalo Sáenz de Santa María-Diez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
European Journal of Case Reports in Internal Medicine
|
November 13, 2025
Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease
Nuria Reina-Llompart, Soledad Serrano-López, Gabriel Torres-Iglesias, et al.
European Journal of Case Reports in Internal Medicine
|
November 13, 2025
Erratum: [Erratum] Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease
Nuria Reina-Llompart, Soledad Serrano-López, Gabriel Torres-Iglesias, et al.
Frontiers in Neurology
|
March 8, 2021
A New Software for Quantifying Motor Deficit After Stroke: A Case-Control Feasibility Pilot Study
Raquel Gutiérrez Zúñiga, María Alonso de Leciñana, Alejandro Díez, et al.
International Journal of Molecular Sciences
|
September 28, 2023
Antibody Content against Epstein-Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing-Remitting Multiple Sclerosis
Mireya Fernández-Fournier, MariPaz López-Molina, Gabriel Torres Iglesias, et al.
International Journal of Molecular Sciences
|
October 16, 2024
Differential Protein Expression in Extracellular Vesicles Defines Treatment Responders and Non-Responders in Multiple Sclerosis
Gabriel Torres Iglesias, MariPaz López-Molina, Lucía Botella, et al.
Diseases (Basel, Switzerland)
|
December 24, 2025
Immunological Monitoring During Anti-CD20 Therapies to Predict Infection Risk and Treatment Response in Multiple Sclerosis Patients
Gabriel Torres Iglesias, Ana Martínez-Feito, Laura Otero-Ortega, et al.
Digital Health
|
January 30, 2025
Digital tool as speech and language therapy for patients with post-stroke aphasia
Gerardo Ruiz Ares, Marta Martin Alonso, Ricardo Rigual, et al.
Journal of Neurology
|
April 5, 2024
Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA study
Ricardo Rigual, Jorge Rodríguez-Pardo, Manuel Lorenzo-Diéguez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
June 19, 2025
Extracellular Vesicle-Derived MicroRNAs as a Biomarker for Therapeutic Response in Multiple Sclerosis
Gabriel Torres-Iglesias, MariPaz López-Molina, Rubén Ayala-Suárez, et al.
Frontiers in Immunology
|
November 5, 2025
Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis
MariPaz López-Molina, Gabriel Torres Iglesias, Gonzalo Sáenz de Santa María-Diez, et al.
Page
of 2